(Allergan plc)

	AGN latest price $208.4947 (-3%) ($207.2303 - $218.3683) on Thu. May. 12, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.82% (three month average)
RSI	39
Latest Price	$208.4947(-3%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.5% a day on average for past five trading days.
Weekly Trend	AGN declines -1.4% a week on average for past two weeks.
Market Behavior	Normal for large cap. Growth stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(53%)    XLV(51%)    XBI(47%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -1.41% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-13%)    SHY(-4%)    IPO(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.41% (StdDev 2.82%)
Hourly BBV	0 ()
Intraday Trend	-3.6%

Resistance Level	$211.4
5 Day Moving Average	$208.3(0.09%)
10 Day Moving Average	$207.92(0.28%)
20 Day Moving Average	$211.4(-1.37%)
To recent high	-27.7%
To recent low	7.1%
Market Cap	$68.741b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed